mortality/aging
|
• mice have reduced lifespans relative to wild-type; mice start to die at 21 weeks of age
|
growth/size/body
|
• symptomatic mice are visibly smaller than normal littermates at 6.5 months
(J:130775)
|
weight loss
(
J:130775
)
behavior/neurological
|
• symptomatic mice can be distinguished from normal littermates at 6.5 months of age by poorly groomed appearance
|
|
• displayed by some mice
|
|
• onset of progressive motor impairment is 7 weeks of age
|
|
• mice show better initial performance relative to the other transgenic lines, then show a steady decline in performance
(J:130775)
• decreased rotarod performance
(J:221703)
|
|
• some mice exhibit spontaneous seizures
|
nervous system
|
• some mice exhibit spontaneous seizures
|
|
• TBP-71Q is relatively diffuse in neuronal nuclei in the brain
|
|
• degenerating Purkinje cells are evident in cerebellum
|
|
• loss or disruption of calbindin-positive neurites in cerebellar molecular layer is observed in mutants
|
|
• degenerating axons are evident in cerebellum; axons with reduced internal space surrounded by a distorted or thickened myelin sheath, presence of myelin ovoids, or vacuolated axons without distinguishable organelles or disintegrating myelin sheaths are indicative of more severe degeneration
|
cellular
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| spinocerebellar ataxia 17 | DOID:0050967 |
OMIM:607136 |
J:130775 | |


Analysis Tools